Total Payments
$169,186
2024 Payments
$9,815
Companies
58
Transactions
1,104
Medicare Patients
4,320
Medicare Billing
$493,055
Payment Breakdown by Category
Other$87,813 (51.9%)
Research$29,697 (17.6%)
Food & Beverage$23,115 (13.7%)
Consulting$17,113 (10.1%)
Travel$10,845 (6.4%)
Education$603.94 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $87,813 | 106 | 51.9% |
| Unspecified | $29,697 | 4 | 17.6% |
| Food and Beverage | $23,115 | 930 | 13.7% |
| Consulting Fee | $17,113 | 4 | 10.1% |
| Travel and Lodging | $10,845 | 40 | 6.4% |
| Education | $603.94 | 20 | 0.4% |
Payments by Type
General
$139,489
1,100 transactions
Research
$29,697
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $64,078 | 133 | $0 (2024) |
| SANOFI US SERVICES INC. | $29,697 | 4 | $0 (2023) |
| Tandem Diabetes Care, Inc. | $29,331 | 101 | $0 (2024) |
| Lilly USA, LLC | $23,575 | 123 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $4,686 | 9 | $0 (2018) |
| Dexcom, Inc. | $3,297 | 26 | $0 (2024) |
| Novo Nordisk Inc | $2,361 | 182 | $0 (2024) |
| Insulet Corporation | $1,257 | 63 | $0 (2024) |
| Abbott Laboratories | $1,008 | 59 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $993.31 | 46 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,815 | 140 | SANOFI-AVENTIS U.S. LLC ($7,044) |
| 2023 | $31,907 | 92 | SANOFI US SERVICES INC. ($29,697) |
| 2022 | $3,826 | 165 | Tandem Diabetes Care, Inc. ($569.10) |
| 2021 | $4,339 | 120 | DEXCOM, INC. ($2,101) |
| 2020 | $7,956 | 121 | Tandem Diabetes Care, Inc. ($5,900) |
| 2019 | $6,823 | 114 | Tandem Diabetes Care, Inc. ($4,446) |
| 2018 | $18,317 | 121 | SANOFI-AVENTIS U.S. LLC ($8,411) |
| 2017 | $86,203 | 231 | SANOFI-AVENTIS U.S. LLC ($47,902) |
All Payment Transactions
1,104 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.99 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $131.44 | General |
| Category: Automated insulin delivery system | ||||||
| 12/03/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Automated insulin delivery system | ||||||
| 11/26/2024 | Radius Health, Inc. | — | Food and Beverage | In-kind items and services | $114.58 | General |
| 11/22/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $32.70 | General |
| Category: Endocrinology | ||||||
| 11/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $2.91 | General |
| Category: Obesity | ||||||
| 11/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $75.21 | General |
| 11/21/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Bone Health | ||||||
| 11/19/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/14/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $123.66 | General |
| Category: Endocrinology | ||||||
| 11/13/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Consulting Fee | Cash or cash equivalent | $5,160.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/13/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 11/13/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Automated insulin delivery system | ||||||
| 11/13/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $24.53 | General |
| Category: Insulin Pump | ||||||
| 11/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Diabetes Care | ||||||
| 11/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: DIABETES | ||||||
| 11/08/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $28.20 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 11/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Cardio-renal | ||||||
| 11/05/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/01/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Obesity | ||||||
| 10/31/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Endocrinology | ||||||
| 10/28/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: ENDOCRINE AGENT | ||||||
| 10/25/2024 | Azurity Pharmaceuticals, Inc. | TRIPTODUR (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.08 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $2.76 | General |
| Category: Obesity | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Multicenter, Multinational Extension of Study PRV-031-001 to Evaluate the Long-Term Safety of Teplizumab (PRV-031), a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children and Adolescents With Recent-Onset Type 1 Diabetes Mellitus | SANOFI US SERVICES INC. | $29,697 | 4 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 940 | 45,295 | $556,337 | $112,672 |
| 2022 | 13 | 1,119 | 37,845 | $550,933 | $118,616 |
| 2021 | 13 | 1,144 | 57,361 | $651,404 | $142,231 |
| 2020 | 12 | 1,117 | 57,491 | $656,847 | $119,536 |
Total Patients
4,320
Total Services
197,992
Medicare Billing
$493,055
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 402 | 886 | $327,820 | $74,768 | 22.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 84 | 102 | $50,592 | $12,294 | 24.3% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 58 | 79 | $40,606 | $6,979 | 17.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 57 | 57 | $31,977 | $6,164 | 19.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 28 | 28 | $19,740 | $4,091 | 20.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 326 | $22,494 | $3,068 | 13.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 45 | 67 | $5,226 | $1,055 | 20.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 31 | 41 | $5,043 | $985.68 | 19.5% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2023 | 16 | 43,460 | $43,460 | $937.02 | 2.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 22 | 22 | $3,388 | $889.98 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 13 | $3,289 | $682.20 | 20.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 152 | 202 | $2,222 | $645.21 | 29.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 11 | 12 | $480.00 | $114.24 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 392 | 872 | $322,640 | $74,153 | 23.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 115 | 150 | $74,400 | $19,820 | 26.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 54 | 54 | $30,294 | $6,332 | 20.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 22 | 22 | $15,510 | $3,585 | 23.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 30 | 335 | $23,115 | $3,058 | 13.2% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 17 | 25 | $12,850 | $2,567 | 20.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 76 | 159 | $12,402 | $2,536 | 20.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 225 | 573 | $6,303 | $1,851 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 27 | $6,831 | $1,454 | 21.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 103 | 122 | $4,850 | $1,162 | 24.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 19 | 20 | $3,080 | $736.63 | 23.9% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 20 | 26 | $3,198 | $707.31 | 22.1% |
About Dr. Steven Leichter, M.D
Dr. Steven Leichter, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Columbus, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1548302201.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Leichter, M.D has received a total of $169,186 in payments from pharmaceutical and medical device companies, with $9,815 received in 2024. These payments were reported across 1,104 transactions from 58 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($87,813).
As a Medicare-enrolled provider, Leichter has provided services to 4,320 Medicare beneficiaries, totaling 197,992 services with total Medicare billing of $493,055. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Columbus, GA
- Active Since 02/12/2007
- Last Updated 07/08/2007
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1548302201
Products in Payments
- SOLIQUA (Drug) $47,603
- TZIELD (Biological) $36,732
- t-slim insulin pump (Device) $22,783
- BASAGLAR (Drug) $16,361
- TOUJEO (Drug) $8,744
- t:slim X2 insulin pump (Device) $5,900
- XARELTO (Drug) $4,583
- DEXCOM G6 TRANSMITTER (Device) $2,101
- Omnipod (Device) $1,257
- JARDIANCE (Drug) $1,107
- Ozempic (Drug) $900.71
- Kerendia (Drug) $830.75
- TRULICITY (Drug) $662.58
- DEXCOM CGM (Device) $661.53
- t:slim X2 Insulin Pump with Control-IQ (Device) $647.99
- Tymlos (Drug) $604.35
- iLet Bionic Pancreas (Device) $556.92
- Korlym (Drug) $457.54
- Dexcom G6 Transmitter (Medical Supply) $384.19
- SOLIQUA 100/33 (Biological) $370.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Columbus
Elena Christofides, Md, Face, MD, FACE
Endocrinology, Diabetes & Metabolism — Payments: $2.7M
Endocrinology, Diabetes & Metabolism $2.7M
Samuel Anderson, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $923,034
Endocrinology, Diabetes & Metabolism $923,034
Ravi Dhawale, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $436,543
Endocrinology, Diabetes & Metabolism $436,543
Kathleen Wyne, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $286,006
Endocrinology, Diabetes & Metabolism $286,006
Constantine Kroustos, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $144,793
Endocrinology, Diabetes & Metabolism $144,793
Laura Ryan, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $135,590
Endocrinology, Diabetes & Metabolism $135,590